Robert More's Trading History
| VIRVir Biotechnology | Aug 12, 2026 | Director | Uninformative Sell | ― | $6.31M | |
| TYRATyra Bioscience | Dec 19, 2025 | Director | Uninformative Sell | 250.00K | $80.56M | |
| ALLKAllakos | Mar 05, 2021 | ― | Informative Sell | 3.72M | $681.41K | |
| SNNAQSienna Biopharmaceuticals | Feb 26, 2019 | Director | Informative Buy | 250.00K | ― | |
| VOLCVolcano Corp | ― | ― | ― | ― | ||
| PRTKParatek Pharmaceuticals | ― | ― | ― | $164.07K | ||
| SOMXSomaxon Pharmaceuticals | ― | ― | ― | ― | ||
| SNTSSantarus | ― | ― | ― | ― | ||
| CADXCadence Pharma | ― | ― | ― | ― | ||
| OREXQOrexigen | ― | ― | ― | $502.90 | ||
| VNDAVanda | ― | Ten Percent Owner | ― | $79.85K | ||
| NUVANuVasive | ― | ― | ― | $318.00K |
You May Also Like
Robert More insider profile FAQ
What is the percentage of profitable transactions made by Robert More?
The percentage of profitable transactions made by Robert More is 33%.
What is the average return per transaction made by Robert More?
The average return per transaction made by Robert More is -8.90%.
What stocks does Robert More hold?
Robert More holds: VIR, NUVA, SNNAQ, ALLK, TYRA, VNDA, OREXQ, CADX, SNTS, SOMX, PRTK, VOLC stocks.
What was Robert More's most profitable transaction?
Robert More’s most profitable transaction was an Informative Sell of ALLK stock on March 5, 2021. The return on the trade was 95.80%.
What is Robert More's role in Vir Biotechnology?
Robert More's role in Vir Biotechnology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.